When was tobi approved




















Monitor renal function as needed. Embryo-fetal toxicity. Nursing mothers: monitor infants. Concomitant ethacrynic acid, furosemide, urea, IV mannitol: not recommended. Diuretics may increase toxicity. Cough, lung disorder, productive cough, dyspnea, pyrexia, oropharyngeal pain, dysphonia, hemoptysis, headache; hearing loss, tinnitus, nephrotoxicity, bronchospasm. Adverse Reactions: Cough, lung disorder, productive cough, dyspnea, pyrexia, oropharyngeal pain, dysphonia, hemoptysis, headache; hearing loss, tinnitus, nephrotoxicity, bronchospasm.

How Supplied: Caps—8, 56, w. Podhaler device. Nightingale SL. Coronavirus Resource Center. Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy Continue. Twitter Facebook. This Issue. Citations 0. View Metrics. News From the Food and Drug Administration. March 4, Stuart L. Nightingale, MD.

Author Affiliations Not Available. Access through your institution. Add or change institution. Save Preferences.



0コメント

  • 1000 / 1000